These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 26234354)
1. [The Role of GRK2 and Its Potential as a New Therapeutic Target in Diabetic Vascular Complications]. Taguchi K Yakugaku Zasshi; 2015; 135(8):961-7. PubMed ID: 26234354 [TBL] [Abstract][Full Text] [Related]
2. Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving β-arrestin 2 translocation and ameliorating Akt/eNOS signal dysfunction. Taguchi K; Matsumoto T; Kamata K; Kobayashi T Endocrinology; 2012 Jul; 153(7):2985-96. PubMed ID: 22581458 [TBL] [Abstract][Full Text] [Related]
3. Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels. Taguchi K; Sakata K; Ohashi W; Imaizumi T; Imura J; Hattori Y J Pharmacol Exp Ther; 2014 May; 349(2):199-208. PubMed ID: 24570070 [TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor kinase 2, with β-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta. Taguchi K; Matsumoto T; Kamata K; Kobayashi T Diabetes; 2012 Aug; 61(8):1978-85. PubMed ID: 22688330 [TBL] [Abstract][Full Text] [Related]
5. Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/Akt activation in aortas of ob/ob mice. Taguchi K; Kobayashi T; Matsumoto T; Kamata K Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H571-83. PubMed ID: 21572010 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II causes endothelial dysfunction via the GRK2/Akt/eNOS pathway in aortas from a murine type 2 diabetic model. Taguchi K; Kobayashi T; Takenouchi Y; Matsumoto T; Kamata K Pharmacol Res; 2011 Nov; 64(5):535-46. PubMed ID: 21571071 [TBL] [Abstract][Full Text] [Related]
9. Co-treatment with clonidine and a GRK2 inhibitor prevented rebound hypertension and endothelial dysfunction after withdrawal in diabetes. Taguchi K; Bessho N; Hasegawa M; Narimatsu H; Matsumoto T; Kobayashi T Hypertens Res; 2018 Apr; 41(4):263-274. PubMed ID: 29463871 [TBL] [Abstract][Full Text] [Related]
10. Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis. Taguchi K; Hida M; Hasegawa M; Narimatsu H; Matsumoto T; Kobayashi T Sci Rep; 2017 Aug; 7(1):8436. PubMed ID: 28814745 [TBL] [Abstract][Full Text] [Related]
11. Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice. Taguchi K; Matsumoto T; Kamata K; Kobayashi T Pharmacol Res; 2012 Jan; 65(1):56-65. PubMed ID: 21933713 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and β-arrestin-2 Overexpression in HEK293 Cells. Lowther KM; Uliasz TF; Götz KR; Nikolaev VO; Mehlmann LM PLoS One; 2013; 8(6):e65365. PubMed ID: 23826079 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin Reverses Sepsis-Induced Vasoplegia to Norepinephrine Through Preservation of α1D-Adrenoceptor mRNA Expression and Inhibition of GRK2-Mediated Desensitization in Mouse Aorta. Kandasamy K; Choudhury S; Singh V; Addison MP; Darzi SA; Kasa JK; Thangamalai R; Dash JR; Kumar T; Sultan F; Singh TU; Parida S; Mishra SK J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):100-13. PubMed ID: 26025460 [TBL] [Abstract][Full Text] [Related]
14. β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly. Gatto F; Feelders R; van der Pas R; Kros JM; Dogan F; van Koetsveld PM; van der Lelij AJ; Neggers SJ; Minuto F; de Herder W; Lamberts SW; Ferone D; Hofland LJ Endocrinology; 2013 Dec; 154(12):4715-25. PubMed ID: 24169548 [TBL] [Abstract][Full Text] [Related]
15. Regulation of GPR54 signaling by GRK2 and {beta}-arrestin. Pampillo M; Camuso N; Taylor JE; Szereszewski JM; Ahow MR; Zajac M; Millar RP; Bhattacharya M; Babwah AV Mol Endocrinol; 2009 Dec; 23(12):2060-74. PubMed ID: 19846537 [TBL] [Abstract][Full Text] [Related]
16. Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2. Nogués L; Salcedo A; Mayor F; Penela P J Biol Chem; 2011 Jan; 286(2):1165-73. PubMed ID: 21081496 [TBL] [Abstract][Full Text] [Related]
17. Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury. Huang ZM; Gao E; Fonseca FV; Hayashi H; Shang X; Hoffman NE; Chuprun JK; Tian X; Tilley DG; Madesh M; Lefer DJ; Stamler JS; Koch WJ Sci Signal; 2013 Oct; 6(299):ra95. PubMed ID: 24170934 [TBL] [Abstract][Full Text] [Related]
18. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression. Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936 [TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway. Ying L; Li N; He Z; Zeng X; Nan Y; Chen J; Miao P; Ying Y; Lin W; Zhao X; Lu L; Chen M; Cen W; Guo T; Li X; Huang Z; Wang Y Cell Death Dis; 2019 Sep; 10(9):665. PubMed ID: 31511499 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic regulation of the sphingosine 1-phosphate receptor miles apart by G protein-coupled receptor kinase 2. Burczyk M; Burkhalter MD; Blätte T; Matysik S; Caron MG; Barak LS; Philipp M Biochemistry; 2015 Jan; 54(3):765-75. PubMed ID: 25555130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]